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Cet article relate une discussion sur 
quelques implications etproblk.mes de 
la santi reproductrice des femrnes et 
leur bien-etrequi ontsuivi lediscours et 
le dkveloppement et le lancement en 
2003 du contraceptiforal: Seasonale 
In September 2003, in a move much 
debated and discussed in the North 
American media, Barr Laboratories 
received U.S. FDA approval to re- 
lease Seasonale on to the prescription 
drug market. Seasonale is a 
- 
repackaging of low-dose birth con- 
trol pills' in an extended regimen 
consisting of 84 straight days of use 
instead of the previously prescribed 
21 days, followed by a seven day pill- 
free interval. Its release gave formal 
medical approval to the practice of 
long-term menstrual suppression 
achieved through continuous birth 
control pill use-much longer than 
84 days in some cases-which has 
been quietly carried out by thou- 
sands of women, for a variety of 
reasons, for at least the last two dec- 
ades. Some of the public discourse 
surrounding this event has been 
fuelled by the publication of a book 
in 1999 by Brazilian gynecologist, 
Dr. Elsimar Coutinho and popula- 
tion scientist, Dr. Sheldon Segal, 
entitled Is Menstruation Obsolete? 
Coutinho and Segal's main thesis is 
that menstruation is useless and harm- 
h1 to women, their families, and to 
society. He argues that menstruation 
is an evolutionary anomaly, which 
has become an inconvenience and a 
hassle for women and suggests that 
those who do not agree with him are 
misguided and out of date. 
The extent of the discussion and 
debate that has accompanied these 
events is not a novel aspect of the 
hormonal contraception issue-there 
is an abundant body of literature and 
commentary on what has come to be 
known as the "Pill" (Marks). How- 
ever there is a sense, which comes 
through in the discourse surround- 
ing these recent events that the em- 
phasis has shifted from a concern 
with birth control to one of men- 
strual control. Made explicit in 
Coutinho and Segal's book, this shift 
is also alluded to on the Seasonale 
website in the trademark slogan, 
"Fewer Periods. More Possi- 
b i l i t i e ~ . ~ ~ "  This can be read as a 
seemingly unintended ironic play on 
the promise of the Pill, marketed to 
millions of women on the implied 
assurance of "fewer possibilities" of 
pregnancy. And the issue of men- 
strual control forms the basis of a 
lively and intimately detailed discus- 
sion thread on the Museum of Men- 
struation website, which, since it 
started in December 2000, has re- 
ceived contributions from hundreds 
ofwomen throughout North America 
and Europe, responding to museum 
curator, Harry Finley's question, 
"Would you stop menstruating if 
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you could?" 
There is a significant body of femi- 
nist scholarship which explores the 
connection between the creation and 
development of reproductive tech- 
nologies-of which Seasonale is one 
of many-and age-old beliefs and 
assumptions about "woman's nature" 
(Martin, Wajcman, Corea). Such 
beliefs and assumptions have been 
analyzed and deconstructed and femi- 
nist theorists and activists alike 
(Bordo) have exposed and delineated 
the social, political, and economic 
impact on women ofthe most central 
of these-the idea that women are 
inferior or less worthy as a result of 
their reproductive functions and ca- 
pabilities. Cross-culturally and since 
ancient times, say these feminists, the 
so-called evidence for women's sec- 
ondary status, manifest in their out 
of control, substance-exuding, form- 
changing bodies and their subsemi- 
ent sexual and familial roles, has been 
summoned up to deny, subjugate, 
and oppress them (Duden). 
However, as part of her contribu- 
tion to a series of articles on contra- 
ception, which ran in the national 
Canadian newspaper, the Globe and 
Mail, columnist Margaret Wenteput 
forward the argument that such con- 
ditions no longer exist for most 
women in contemporary Anglo- 
American and Western European 
society. This, she claims, is due in 
large part to the so-called sexual revo- 
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lution brought on by the introduc- 
tion of the Pi11 in the early 1960s. 
Wente is obviously not alone in this 
analysis (see Tone). There is broad 
and popular acceptance of the idea 
that the introduction of the Pill has 
had a dramatic impact on these soci- 
eties and on the lives of women in 
particular, as a result of the fact that 
the Pill, in all its various mutations, 
has provided them with the histori- 
like the Pill itself, not something that 
has gained universal acceptance. Is- 
sues of morality, ideology, and fam- 
ily values, as well as immediate and 
long-term health effects that are both 
directly and indirectly related to Pill 
use, are, as the Seasonale story dem- 
onstrates, still very much matters of 
debate (Gordon and Gordon). And 
while, as a result of changing social 
values and technological advances, 
The phatmaceuticaf "rndtlstry is moving into the 
business c3tf disease-creation, a tore histori~alty 
dominated by physicians, which involves framing 
normal bodily experiences less as diseases 
themselves, but: as causes of future diseases. 
cally unprecedented ability to more 
or less effectively and safely control 
their fertility. In her recent book, Dr. 
Penny Le Couteur comments that in 
the last 40 years, in countries where 
the Pill and other similar hormo- 
nally-based contraceptives have be- 
come widely available, 
the birth rate has dropped, and 
women have gained more edu- 
cation and have entered the 
workforce in unprecedented 
numbers: in politics, in business 
and in trade, women are no 
longer an exception. (Le Couteur 
and Burreson 22 1) 
Le Couteur goes on to conclude 
that the Pill was more than just a 
fertility-controlling medication and 
that its introduction signaleda change 
in awareness. This was not just on 
issues of fertility and contraception, 
but also with regard to women's fa- 
milial and sexual roles, allowing in- 
creasing numbers of them to speak 
out about and take significant steps 
to address the issues of broad-based 
gender inequality, violence, and pov- 
erty underpinning centuries ofwom- 
en's oppression. 
This being said, the idea that the 
Pill has wrought only changes for the 
better, while popularly accepted, is, 
the parameters of the debate have 
altered, it is interesting to consider 
that the concerns being raised by 
those involved in it have some of 
their sources in the conditions and 
circumstances surrounding the crea- 
tion and marketing of the Pill some 
50 years ago. 
For instance, what is perhaps the 
central element of the current con- 
troversy-the issue of continuous 
use-has its origins in the particular 
characteristics of the development 
and testing phase of the initial ver- 
sions of the Pill undertaken in the 
U.S. in the late '50s and early '60's 
(Oudshoorn). These were a conse- 
quence of the attempt to maneuver 
the prototype Pill through the con- 
servative social climate and the ob- 
stacles raised by the leadership of the 
Catholic Church regarding the arti- 
ficial, and therefore unacceptable, 
method of birth control presented by 
the Pill. Initially deriving from hor- 
monal drugs and therapies that were 
created to treat fertility and men- 
strual problems through a program 
of short- to medium-term continu- 
ous use-this could be a interlude of 
a number of months to a number of 
years depending on the need and the 
problem-the version of the Pill that 
its main creator, the devoutly Catho- 
lic obstetrician, John Rock, intro- 
duced on to the market was specifi- 
cally formulated to mask these ori- 
gins. Such a formulation was the 
outcome of the need for Rock and 
the Pill's CO-creator, Gregory Pincus, 
to produce what Margaret Sanger- 
champion of the birth control move- 
ment in America (see Tone)-de- 
scribed as a safe, cheap, reliable, 
"magic pill" (208) that could be swal- 
lowed like an aspirin, and that would 
meet the demands ofthe Church and 
its social conservative allies for a birth 
control method that was "natural" 
and "God-given." Rock and Pincus, 
believing they could promote the Pill 
to the Church leadership on the basis 
of it being a method similar to the 
Church-approved "Rhythm Method," 
which simply uses and incorporates 
the "natural" hormonal cycling of 
the body to regulate the possibility of 
conception, "decided to cut the hor- 
mones off after three weeks and trig- 
ger a menstrual period" (Gladwell 
4). This strategy of creating the im- 
pression of "business as usual" in 
women's bodies was also aimed at the 
prospective users, the women them- 
selves, who Rock and Pincus felt 
would be reassured by a continuation 
of their monthly bleeding. 
However, many women, as well as 
the Church leadership were to see 
through this ploy. Since the release of 
its 1968 encyclical outlawing the use 
of all forms of artificial birth control 
by its members, the Roman Catholic 
Church continues to maintain its 
ban on the use of the Pill, a position 
that is also supported by other con- 
temporary religious and neo-con- 
servative movements. As for the 
women, increasing numbers of 
them-80 per cent of American 
women born since 1945 have used 
oral contraceptives (Tone)-have 
rejected the edicts of traditional reli- 
gious and conservative ideology and 
taken control oftheir fertility through 
the Pill. Andas for ~ o c k ' s  and Pincus's 
attempt to give women the assurance 
of regular menstrual cycles while on 
the Pill, there are a numerous refer- 
ences in the literature to the so-called 
"honeymoon tr ick (Rabin), whereby 
CANADIAN WOMAN STUDIESILES CAHIERS DE LA FEMME 
women plan continuous pill talung 
around a special event, suggesting 
that the practice of continuous use 
was adopted bywomen not long after 
the Pill's introduction and has con- 
tinued to grow since then. 
Recently, attention has focused on 
the extent to which this latter prac- 
tice is connected with the "market- 
ing" and commercialization of dis- 
ease prevention and control and how 
this relates to the use of the precur- 
sors of the Pill in the treatment of 
reproductive and menstrual disor- 
ders (Lippman). These disorders in- 
- - 
clude a whole range of conditions 
from mild menstrual discomfort to 
dysmenorrhea, which involves severe 
pain and excessive bleeding. Possibly 
the most widespread contemporary 
use of the Pill in this area is in the 
treatment of a condition that has 
been described as one of the most 
common diseases on the face of the 
earth, endometriosis (see the Endo- 
center website). This statement, 
which is based on the contention that 
endometriosis afflicts over 80 mil- 
lion women world-wide is unfortu- 
nately not supported with references 
to any research data. Interestingly 
enough, a lack of supportive refer- 
ences and citations is far from the 
exception in this area of the litera- 
ture. There is no supportive data 
cited for the other main therapeutic 
use of the Pill, the prevention of ova- 
rian and endometrial cancer, which 
Malcolm Gladwell, for instance, 
claims are reduced in Pill users by 70 
and 60 per cent respectively ( 7). 
While acknowledging the docu- 
mented beneficial effects of the Pill 
and other hormonal compounds in 
the treatment of reproductive system 
pathologies, I would like to suggest 
that this issue of unsubstantiated 
claims, which are widely quoted in 
the popular literature, is one among 
a number of issues that are part of a 
growing trend to promote drugs and 
therapies, including the Pill, for their 
preventive benefits. Women's health 
activist and McGill University Pro- 
fessor Abby Lippman has discussed 
this trend, coining the term "neo- 
medicalization" to describe what she 
claims are two new variations, deriv- 
ing from contemporary economic 
forces, on the historic and cross-cul- 
tural practice of medicalizing wom- 
en's lives, in particular their repro- 
ductive lives. In the first   lace, she 
argues, the pharmaceutical industry 
is moving into the business of dis- 
ease-creation, a role historically domi- 
nated by physicians. Lippman de- 
hormonal deficiency or imbalance 
and was also labeled as the cause of 
other conditions such as heart disease 
and osteoporosis. She suggests that 
this framing of menopause as a cause 
of subsequent problems meant that 
even when the disease label fell out of 
favour, the treatment of menopause 
in the form ofEstrogen Replacement 
Therapy (ERT) and combined 
Estrogen and Progesterone Replace- 
Menstruation is being cast in the same way 
as menopause, as a problem of pathology that 
needs to be "fixed" or "eliminated" for not 
just its immediate undesirable efiects but also 
because of its disease-causing potential. 
scribes an interrelated development, 
which involves the framing of nor- 
mal bodily experiences less as dis- 
eases themselves, but as causes of 
future diseases. She claims that the 
phenomenon of neo-medicalization 
fits seamlessly in the consumer- 
oriented society of North 
America today and to current 
views of disease-if not "pre- 
diseasen-as a "market oppor- 
tunity!" For example, this latest 
medicalization comes packaged 
as individual "choice" with the 
offer of multiple "options" to 
women. Thus, both neo- 
medicalization and consumer- 
ism construct health as a com- 
modity, a resource needed for 
economic growth, and both em- 
phasize increasing women's 
choices (via the creation of tests, 
screening exams, etc.). Further, 
by framing life experiences as 
"causes" of disease, neo-medi- 
calization thereby generates a 
whole industry to create "pills 
for prevention. ( 9) 
T o  illustrate this argument, 
Lippman looks at how the transi- 
tional state in women's lives known 
as menopause came to be understood 
and treated as a disease caused by 
ment Therapy (HRT) continued to 
be recommended by the medical com- 
munity because it was now seen as a 
measure preventing the onset of the 
diseases brought on by menopause. 
The negative consequences to wom- 
en's health of such an approach have, 
argues Lippman, been recently re- 
vealed in the outcomes of the Wom- 
en's Health Initiative (WHI) in which 
the two arms of a longitudinal, large- 
scale study looking at the effects of 
ERT and HRT on over 16,000 post- 
menopausal women in the U.S. were 
stopped three years earlier than the 
planned end date. The reasons given 
for the premature cancellation of the 
biggest trial of this type in drug trial 
history are outlined on the National 
Institutes of Health (NIH) website 
and include findings of an increased 
risk of invasive breast cancer as well as 
evidence that the overall health risks, 
in the form of increased susceptibil- 
ity to heart attack and stroke, ex- 
ceeded any benefits for the trial par- 
ticipants. 
Menstruation is, Lippman sug- 
gests, being cast in the same way as 
menopause, as a problem of pathol- 
ogy that needs to be "fixed" or "elimi- 
nated for not just its immediate 
undesirable and unwanted effects but 
also because of its disease-causing 
potential. The proponents of this 
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message include the persuasive-be- 
cause difLcult to refute-evolution- 
aryarguments ofcoutinho andsegal, 
who make a similar claim to Beverly 
Strassman, aU.S. anthropologistwho 
has researched the link between breast 
cancer and menstruation. Strassman 
suggests that the much lower rate of 
pregnancy and postpartum amen- 
horrea in women in post-industrial 
society has given rise to a menstrual 
cycle rate that is 300 per cent greater 
than that of their pre-industrial 
foremothers (Strassman). This inces- 
sant ovulation in the form of an 
average of 400 menstrual cycles adds 
up to more than half of a life time's 
worth of monthly discomfort and 
distress for women of child-bearing 
age. In addition, there is the increased 
risk of developing some particularly 
aggressive types of cancers and a 
greater susceptibility to anemia, 
which, Coutinho and Segal argue, is 
one of the most serious health prob- 
lems in the world. 
Other proponents of this argu- 
ment such as American MD, Patricia 
Sulak, demonstrate study evidence 
to support this theory about the ill- 
health effects ofmenstruation (Sulak 
et al.), and use it, as does Dr. Leslie 
Miller, the creator of the NoPeriod 
website, to make their case for the 
elimination of menstruation. Their 
message, which is framed in the lan- 
guage of choice and empowerment 
and aimed at all women of child- 
bearing age, emphasizes the benefits 
of not only minimizing the disease- 
causing potential ofmenstruation but 
ofgetting rid of the hassle and incon- 
venience of the monthly period. And 
this is where the Pill comes in. First 
with the years-old practice of off- 
label continuous use of the short- 
cycle oral contraceptives, which in- 
volves skipping the seven-day por- 
tion of placebos and continuous use 
of the 21 active pills in a Pill prescrip- 
tion. Then with the medically-ap- 
. - 
proved version of this practice in the 
form of the extended cycle oral con- 
traceptive, Seasonale, a package of 84 
active pills and seven placebos, offi- 
cially launched by the manufactur- 
ers, Barr Laboratories at the end of 
2003, and which is set for release in 
Canada within the next few months. 
And in the future, with the smaller 
dose, longer-use versions that are in 
the development pipelines of Barr 
and some ofthe other major pharma- 
ceutical companies. With a potential 
target market of half the population 
combined with the high profit mar- 
gin on birth control pills (Tone), as 
well as the greatly shortened research 
and development phase required for 
this incarnation of the Pill, it is not 
hard to see why the pharmaceutical 
companies seem to be staking out 
more space in an already lucrative 
market. Just as ERT and HRT was 
and is to menopause, so the Pill is and 
can be to menstruation, taking up 
center-stage with its dual roles in the 
processes of birth control and men- 
strual control. 
Lippman's perspective is shared by 
other women's health advocates who 
believe that outcomes such as those 
that have come out of the Women's 
Health Initiative study should serve 
as a strong warning about the poten- 
tial consequences of the neo- 
medicalization of menstruation. 
These include the members of the 
Society for Menstrual Cycle Research 
(SMCR), which is an organization 
comprised of reproductive health 
professionals, researchers, and activ- 
ists from across North America, as 
well as Brazil and Australia. SMCR 
has, over the course of its 30-year 
history, been influential in raising 
questions about the risks to women's 
reproductive health of some of the 
mainstream approaches in this area. 
In astatement on the Society'swebsite 
they have referenced findings from 
ongoing studies which were presented 
at the most recent SMCRconference 
in Pittsburgh in 2003 in order to 
articulate their concerns on the issue 
of menstrual suppression. Among 
these findings were ones that emerged 
from Alex Hoyt and Linda Andrist's 
2003 study showing that women's 
negative attitudes toward the men- 
- 
strual cycle were a better predictor of 
women's interest in menstrual sup- 
pression than women's menstrual 
symptoms, suggesting the importance 
of psychosocial factors in women's 
decision-making about altering their 
menstruation. The possible source of 
some of these psychosocial factors 
was alluded to by Ingrid Johnston- 
Robledo and Jessica Barnack, whose 
study demonstrated a distinct bias in 
print-media coverage of menstrual 
suppression, whereby regular men- 
struation was portrayed as bother- 
some and even unhealthy and more 
space was given to the proponents of 
menstrual suppression and its ben- 
efits. Furthermore, a review of stud- 
ies on extended cycle oral contracep- 
tive use by Christine Hitchcock and 
Jerilynn Prior concluded that, as a 
result of a lack of well-designed, pla- 
cebo-controlled, randomized trials, 
which examine women's experience, 
bone health and risks for blood clots 
and strokes, and which look at the 
particular risks faced by adolescents, 
there is not yet enough evidence to 
suggest that menstrual suppression is 
entirely safe and reversible. All this 
leads the SMCRmembership to con- 
clude that, as with many other health 
issues, women are not getting accu- 
rate, balanced information thus ren- 
dering an informed decision about 
this healthcare option difficult if not 
impossible. 
Yet while there are potential 
learnings from the menopause and 
WHI study (see Lippman) there are 
also different concerns. Someofthese 
are centered on the Pill's history as a 
safe and effective form of birth con- 
trol and a harbinger of reproductive 
and sexual freedom for a generation 
- 
of women as well as the role this will 
play in influencingwomen's response 
to, and acceptance of, the promotion 
of menstrual suppression. It is prob- 
ably safe to say that the pharmaceuti- 
cal companies are counting on this 
being an important factor in paving 
the way for the potential adoption of 
this practice among women who have 
the resources and ability to take ad- 
vantage of it. Barr laboratories re- 
- 
ported strong acceptance of men- 
strual suppression in results from their 
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clinical trials of Seasonale, in which 
over 1,400 women participated for a 
period of 12 months (Anderson and 
Hait). The strength of these results 
has since been called into question as 
closer analysis of the Barr data shows 
that of the456 women who were in 
the Seasonale subgroup, 185 or 40 
per cent, left before the end of the 
study with the majority of them cit- 
ing the problem of break through or 
mid-cycle bleeding as the reason for 
quitting the trial prematurely (Rabin). 
However, in a press release issued in 
May 2004, Barr stated that initial 
sales of Seasonale had far exceeded 
their expectations and they were tak- 
ing steps to triple their sales and 
support staff in order to keep up with 
demand (Hardy). An in-depth ex- 
amination of these results and re- 
ports will be among the many tasks 
required in order to fully chart and 
analyze the Pill's makeover into a 
tool of menstrual control. 
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Levonorgestrel and 0.03mg ofEthinyl 
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